Skip to content
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Clinical Topics
View All
Depression
Neurologic
Anxiety
Schizophrenia
Trauma
Psychopharmacology
Bipolar
Tardive Dyskinesia
OCD
Addiction
View All
Columns
View All
ASCP Corner
Clinical & Practical Psychopharmacology
Rounds General Hospital
Academic Highlights
Banner Alzheimer’s Institute
Focus on Geriatric Psychiatry
David Michelson
JCP
Original Research
Addition of Atomoxetine for Depression Incompletely Responsive to Sertraline: A Randomized, Double-Blind, Placebo-Controlled Study
JCP
Original Research
Atomoxetine and Adult Attention-Deficit/Hyperactivity Disorder: The Effects of Comorbidity.
JCP
Original Research
Changes in Adverse Events Reported by Patients During 6 Months of Fluoxetine Therapy
JCP
Letter to the Editor
Comparing the Efficacy and Safety of Fluoxetine and Venlafaxine in Outpatient Depression
PCC
Article
Drug Development Process for a Product with a Primary Pediatric Indication
JCP
Original Research
Long-Term, Open-Label Study of the Safety and Efficacy of Atomoxetine in Adults With Attention-Deficit/Hyperactivity Disorder: An Interim Analysis
JCP
Original Research
Long-Term Treatment Outcomes of Depression With Associated Anxiety: Efficacy of Continuation Treatment With Fluoxetine
JCP
Original Research
Randomized Controlled Study of the Histamine H3 Inverse Agonist MK-0249 in Adult Attention-Deficit/Hyperactivity Disorder
JCP
Article
Drug Development Process for a Product with a Primary Pediatric Indication